What is the current Viral Transport Media market size?

The current Viral Transport Media market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Viral Transport Media market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Viral Transport Media market?

Key drivers include rising infectious disease prevalence and growing demand for diagnostic testing solutions.

What are the major challenges facing the Viral Transport Media market?

Challenges include stringent regulatory requirements and competition from alternative diagnostic methods.

Which regions are expected to lead the Viral Transport Media market?

North America and Europe are expected to dominate the market due to established healthcare infrastructure.

Who are the top companies in the Viral Transport Media market?

Leading companies include Thermo Fisher, BD, and Merck, which offer a range of viral transport media products.

What future opportunities exist in the Viral Transport Media market?

Emerging opportunities include the development of new diagnostic technologies and expanding into emerging markets.

How will technology impact the Viral Transport Media market?

Advances in technology will enable more efficient and accurate diagnostic testing, driving market growth and innovation.

What is the current regulatory landscape for the Viral Transport Media market?

The market is subject to strict regulatory requirements, including those related to product safety and efficacy.

What is the future outlook for the Viral Transport Media market?

The future outlook is positive, with increasing demand for diagnostic testing and emerging opportunities in new markets.

Viral Transport Media Market Potential & Strategic Outlook 2033

Viral Transport Media by Application (Microbiology Laboratories, Diagnostic Laboratories, Others), by Types (1ml, 2ml, 3ml, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 114

Forecast Period: 2026 - 2033

Market Size: $1234 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Viral Transport Media Market Overview

The Viral Transport Media (VTM) market refers to the global industry involved in the production and distribution of media used for the transportation and preservation of viral samples. As the Viral Transport Media market size is expected to witness significant growth, driven by the increasing demand for diagnostic testing and research applications, understanding the growth outlook and market forecast is crucial for industry stakeholders. The industry expansion is anticipated to be shaped by factors such as advancements in technology, evolving regulations, and changing consumer behavior, with the global VTM market estimated to be around $1.4 billion in 2025.

Loading chart…

The Viral Transport Media market is expected to grow at a CAGR of around 8% from 2026 to 2033, driven by macro drivers such as the increasing incidence of infectious diseases, advancements in diagnostic technologies, and the rising demand for molecular diagnostics. Key forces shaping the industry include technology shifts towards more efficient and sensitive diagnostic methods, regulations related to the transportation and handling of viral samples, and competitive intensity among market players. The largest region in the VTM market is North America, while the fastest-growing region is expected to be the Asia-Pacific region, driven by the increasing demand for diagnostic testing and research applications in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.32 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Puritan Medical Products; BD; Laboratory Corporation of America; Hardy Diagnostics; VIRCELL; HiMedia Laboratories; MWE; MANTACC; Starplex Scientific; DiaSorin Molecular; Copan
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Viral Transport Media market is witnessing significant growth, driven by increasing demand for effective diagnostic solutions. The market dynamics are influenced by various factors, including technological advancements, regulatory requirements, and shifting consumer preferences.

Growth Drivers2 items

Advances in molecular diagnostics are driving the adoption of Viral Transport Media, enabling accurate and rapid detection of viral infections, which in turn is contributing to the growth forecast of the Viral Transport Media market size

The rising prevalence of infectious diseases is fueling the demand for Viral Transport Media, as it plays a critical role in the safe transportation and storage of viral specimens, thereby supporting the overall growth of the Viral Transport Media market

Restraints2 items

Stringent regulatory requirements and standards for Viral Transport Media are limiting the entry of new players in the market, which may impact the growth forecast of the Viral Transport Media market size

The high cost of production and maintenance of Viral Transport Media is a significant restraint, as it increases the overall cost of diagnostic testing and may affect the Viral Transport Media market size

Opportunities2 items

The increasing demand for point-of-care diagnostics presents a significant opportunity for the Viral Transport Media market, as it enables the development of innovative and user-friendly diagnostic solutions, driving the growth of the Viral Transport Media market size

The growing telemedicine market is expected to drive the adoption of Viral Transport Media, as it requires reliable and efficient diagnostic solutions for remote patient monitoring, contributing to the overall growth forecast of the Viral Transport Media market

Challenges2 items

The global supply chain disruption due to the COVID-19 pandemic has affected the availability and pricing of Viral Transport Media, posing a significant challenge to the market, and may impact the growth forecast of the Viral Transport Media market size

The lack of standardization in Viral Transport Media is a major challenge, as it hinders the comparability and reliability of diagnostic results, which may affect the overall growth of the Viral Transport Media market

Market Segmentation

Loading chart…

The Viral Transport Media market can be segmented based on Application, which refers to the various uses of viral transport media in different fields. This segmentation category contributes significantly to the overall Viral Transport Media market size, as it encompasses a wide range of applications, including diagnostic laboratories, research institutions, and hospitals. The application segment is crucial in understanding the Viral Transport Media segmentation and its impact on the market.

The Types segment of the Viral Transport Media market includes subtypes such as universal transport medium, viral transport medium, and molecular transport medium. Each subtype has its own unique characteristics and uses, catering to specific requirements of various applications. The types segment is vital in determining the market taxonomy and understanding the competitive landscape of the Viral Transport Media market. By analyzing the types segment, researchers can identify opportunities for growth and development in the market.

Viral Transport Media Segmentation Breakdown9 items

Application

Microbiology Laboratories

Diagnostic Laboratories

Others

Types

1ml

2ml

3ml

Others

Regional Insights

Loading chart…

The Viral Transport Media market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and also the fastest-growing region, driven by increasing adoption of viral transport media in clinical settings, government policies supporting healthcare infrastructure development, and investments in research and development. In North America, key drivers include demographics with an aging population, infrastructure with well-established healthcare systems, and an ecosystem maturity with a high level of awareness about viral transport media.

In Europe, the key drivers are policies supporting the use of viral transport media, infrastructure with modern healthcare facilities, and adoption of advanced diagnostic techniques. Latin America's growth is driven by investments in healthcare, demographics with a growing population, and increasing awareness about viral transport media. The Middle East & Africa region is driven by government initiatives to improve healthcare infrastructure, infrastructure development, and adoption of viral transport media in clinical settings, contributing to the regional forecast.

Competitive Landscape

The Viral Transport Media market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Viral Transport Media competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market presence, while local companies concentrate on regional expansion and cost-effective solutions.

Companies in the Viral Transport Media market employ various strategies to differentiate themselves, including mergers and acquisitions, partnerships, product launches, and research and development. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies have adopted distinct strategic focuses:

Thermo Fisher Scientific: regional expansion

Puritan Medical Products: vertical integration

BD: premium pricing

Laboratory Corporation of America: OEM tie-ups

Hardy Diagnostics: innovation pipeline

VIRCELL: local manufacturing

Key Viral Transport Media Companies12 items

Thermo Fisher Scientific

Puritan Medical Products

Laboratory Corporation of America

Hardy Diagnostics

VIRCELL

HiMedia Laboratories

MWE

MANTACC

Starplex Scientific

DiaSorin Molecular

Copan

Market Ecosystem

The Viral Transport Media ecosystem spans multiple stages, from upstream technology providers and suppliers to midstream integrators and channels, and ultimately downstream to end users. This ecosystem is characterized by a complex interplay of value creation and capture, as various participants contribute to the development, manufacturing, and distribution of viral transport media products. Understanding the boundaries and dynamics of this ecosystem is crucial for conducting a thorough value chain analysis.

Raw material suppliers — providing critical components

OEMs / manufacturers — producing viral transport media products

Technology providers — developing innovative solutions

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing viral transport media products

Regulators/standards bodies — establishing industry standards and guidelines

In the Viral Transport Media ecosystem, control points are largely influenced by regulators and standards bodies, as they dictate the approval and adoption of products. Dependency risks arise from input constraints, such as the availability of raw materials, and standards approvals, which can impact product development and distribution. Furthermore, switching costs and partnerships can also affect the ecosystem, as companies may face challenges when transitioning between different suppliers or technologies. The Viral Transport Media ecosystem differs by region, with varying regulatory requirements and market demands influencing the dynamics of value creation and capture.

Recent Industry Insights

The Viral Transport Media industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships, such as collaborations between diagnostic companies and research institutions, aimed at enhancing the sensitivity and specificity of viral transport media. Furthermore, mergers and acquisitions have also been observed, with major players expanding their product portfolios and strengthening their market presence.

Additionally, several product and technology launches have taken place, focusing on improving the stability and shelf-life of viral transport media. These advancements have been driven by the increasing demand for effective and reliable diagnostic solutions. The shift in consumer or enterprise trends towards decentralized testing and point-of-care diagnostics has also fueled innovation in the Viral Transport Media industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Viral Transport Media market outlook. The market exhibits moderate attractiveness due to increasing demand for diagnostic testing and rising awareness about infectious diseases. Competitive intensity is high, with key players investing in research and development to enhance their product portfolios. The long-term outlook appears promising, driven by the growing need for effective viral transport media in various healthcare settings.

The innovation landscape is evolving, with a focus on developing more efficient and user-friendly viral transport media products. However, the demand–supply balance may be affected by factors such as raw material availability and supply chain disruptions. Key risk factors include regulatory changes and intense competition, which may impact market growth. Overall, the Viral Transport Media market is expected to experience steady growth, driven by its essential role in diagnostic testing and disease surveillance.

11 items

1. Executive Summary

2. Viral Transport Media Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Viral Transport Media Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Viral Transport Media Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Microbiology Laboratories

6.1.2. Diagnostic Laboratories

6.1.3. Others

6.2. Global Viral Transport Media Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 1ml

6.2.2. 2ml

6.2.3. 3ml

6.2.4. Others

6.3. Global Viral Transport Media Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Viral Transport Media Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Viral Transport Media Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Viral Transport Media Market Competition by Key Manufacturers

8.1. Global Viral Transport Media Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Viral Transport Media: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Thermo Fisher Scientific

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Puritan Medical Products

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. BD

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Laboratory Corporation of America

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Hardy Diagnostics

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. VIRCELL

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. HiMedia Laboratories

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. MWE

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. MANTACC

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Starplex Scientific

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. DiaSorin Molecular

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Copan

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Viral Transport Media Market

Figure 4: Global Viral Transport Media Market: Drivers

Figure 5: Global Viral Transport Media Market: Challenges

Figure 6: Global Viral Transport Media Market: Trends

Figure 7: Global Viral Transport Media Market: Opportunity

Figure 8: Global Viral Transport Media Market: Restraint

Figure 9: Global Viral Transport Media Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Viral Transport Media Market Value (USD Million) By Region

Figure 15: Global Viral Transport Media Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Viral Transport Media Market Value (USD Million) By Region

Figure 23: Global Viral Transport Media Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Viral Transport Media Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Viral Transport Media Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Viral Transport Media Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Viral Transport Media Market Value (USD Million) By Region

Table 10: Global Viral Transport Media Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Viral Transport Media Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Viral Transport Media Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Viral Transport Media Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Thermo Fisher Scientific Basic Information And Sales Area

Table 31: Thermo Fisher Scientific. Products Portfolio

Table 32: Puritan Medical Products Basic Information And Sales Area

Table 33: Puritan Medical Products. Products Portfolio

Table 34: BD Basic Information And Sales Area

Table 35: BD. Products Portfolio

Table 36: Laboratory Corporation of America Basic Information And Sales Area

Table 37: Laboratory Corporation of America. Products Portfolio

Table 38: Hardy Diagnostics Basic Information And Sales Area

Table 39: Hardy Diagnostics. Products Portfolio

Table 40: VIRCELL Basic Information And Sales Area

Table 41: VIRCELL. Products Portfolio

Table 42: HiMedia Laboratories Basic Information And Sales Area

Table 43: HiMedia Laboratories. Products Portfolio

Table 44: MWE Basic Information And Sales Area

Table 45: MWE. Products Portfolio

Table 46: MANTACC Basic Information And Sales Area

Table 47: MANTACC. Products Portfolio

Table 48: Starplex Scientific Basic Information And Sales Area

Table 49: Starplex Scientific. Products Portfolio

Table 50: DiaSorin Molecular Basic Information And Sales Area

Table 51: DiaSorin Molecular. Products Portfolio

Table 52: Copan Basic Information And Sales Area

Table 53: Copan. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Viral Transport Media Market Value (USD Million) By Region

Table 59: Global Viral Transport Media Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Viral Transport Media Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.32 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Puritan Medical Products; BD; Laboratory Corporation of America; Hardy Diagnostics; VIRCELL; HiMedia Laboratories; MWE; MANTACC; Starplex Scientific; DiaSorin Molecular; Copan
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Viral Transport Media Segmentation Breakdown9 items

Application

Microbiology Laboratories

Diagnostic Laboratories

Others

Types

1ml

2ml

3ml

Others

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: regional expansion

Puritan Medical Products: vertical integration

BD: premium pricing

Laboratory Corporation of America: OEM tie-ups

Hardy Diagnostics: innovation pipeline

VIRCELL: local manufacturing

Key Viral Transport Media Companies12 items

Thermo Fisher Scientific

Puritan Medical Products

Laboratory Corporation of America

Hardy Diagnostics

VIRCELL

HiMedia Laboratories

MWE

MANTACC

Starplex Scientific

DiaSorin Molecular

Copan

Market Ecosystem

Raw material suppliers — providing critical components

OEMs / manufacturers — producing viral transport media products

Technology providers — developing innovative solutions

Distributors / channel partners — facilitating product distribution

Service providers / after-sales — offering support and maintenance

End users / buyers — utilizing viral transport media products

Regulators/standards bodies — establishing industry standards and guidelines

Recent Industry Insights

Analyst Overview

Table of Contents